scholarly journals Molecular inactivation of exopolysaccharide biosynthesis inPaenibacillus polymyxaDSM 365 for enhanced 2,3-butanediol production

2018 ◽  
Author(s):  
Christopher Chukwudi Okonkwo ◽  
Victor Ujor ◽  
Thaddeus Chukwuemeka Ezeji

AbstractFormation of Exopolysaccharides (EPS) during 2,3-butanediol (2,3-BD) fermentation byPaenibacillus polymyxadecreases 2,3-BD yield, increases medium viscosity and impacts 2,3-BD downstream processing. Therefore, additional purification steps are required to rid the fermentation broth of EPS prior to 2,3-BD purification, which adds to the production cost. To eliminate EPS production during 2,3-BD fermentation, we explored a metabolic engineering strategy to disable the EPS production pathway ofP. polymyxa, thereby increasing 2,3-BD yield and productivity. The levansucrase gene which encodes levansucrase, the enzyme responsible for EPS biosynthesis inP. polymyxa, was successfully disrupted. The resultingP. polymyxalevansucrase null mutant showed 34% and 54% increases in growth with 6.4- and 2.4-folds decrease in EPS formation in sucrose and glucose cultures, respectively. The observed decrease in EPS formation by the levansucrase null mutant may account for the 27% and 4% increase in 2,3-BD yield, and 4% and 128% increases in 2,3-BD productivity when grown on sucrose and glucose media, respectively. Genetic stability of the levansucrase null mutant was further evaluated. Interestingly, the levansucrase null mutant remained genetically stable over fifty generations with no observable decrease in growth and 2,3- BD formation with or without antibiotic supplementations. Collectively, our results show thatP. polymyxalevansucrase null mutant has potential for improving 2,3-BD yield, and ultimately, the economics of large-scale microbial 2,3-BD production.

2020 ◽  
Vol 86 (9) ◽  
Author(s):  
Christopher Chukwudi Okonkwo ◽  
Victor Ujor ◽  
Katrina Cornish ◽  
Thaddeus Chukwuemeka Ezeji

ABSTRACT The formation of exopolysaccharides (EPSs) during 2,3-butanediol (2,3-BD) fermentation by Paenibacillus polymyxa increases medium viscosity, which in turn presents considerable technical and economic challenges to 2,3-BD downstream processing. To eliminate EPS production during 2,3-BD fermentation, we used homologous recombination to disable the EPS biosynthetic pathway in P. polymyxa. The gene which encodes levansucrase, the major enzyme responsible for EPS biosynthesis in P. polymyxa, was successfully disrupted. The P. polymyxa levansucrase null mutant produced 2.5 ± 0.1 and 1.2 ± 0.2 g/liter EPS on sucrose and glucose, respectively, whereas the wild type produced 21.7 ± 2.5 and 3.1 ± 0.0 g/liter EPS on the same substrates, respectively. These levels of EPS translate to 8.7- and 2.6-fold decreases in EPS formation by the levansucrase null mutant on sucrose and glucose, respectively, relative to that by the wild type, with no significant reduction in 2,3-BD production. Inactivation of EPS biosynthesis led to a considerable increase in growth. On glucose and sucrose, the cell biomass of the levansucrase null mutant (8.1 ± 0.8 and 6.5 ± 0.3 g/liter, respectively) increased 1.4-fold compared to that of the wild type (6.0 ± 0.1 and 4.6 ± 0.3 g/liter, respectively) grown on the same substrates. Evaluation of the genetic stability of the levansucrase null mutant showed that it remained genetically stable over fifty generations, with no observable decrease in growth or 2,3-BD formation, with or without antibiotic supplementation. Hence, the P. polymyxa levansucrase null mutant has potential for use as an industrial biocatalyst for a cost-effective large-scale 2,3-BD fermentation process devoid of EPS-related challenges. IMPORTANCE Given the current barrage of attention and research investments toward the production of next-generation fuels and chemicals, of which 2,3-butanediol (2,3-BD) produced by nonpathogenic Paenibacillus species is perhaps one of the most vigorously pursued, tools for engineering Paenibacillus species are intensely sought after. Exopolysaccharide (EPS) production during 2,3-BD fermentation constitutes a problem during downstream processing. Specifically, EPS negatively impacts 2,3-BD separation from the fermentation broth, thereby increasing the overall cost of 2,3-BD production. The results presented here demonstrate that inactivation of the levansucrase gene in P. polymyxa leads to diminished EPS accumulation. Additionally, a new method for an EPS assay and a simple protocol employing protoplasts for enhanced transformation of P. polymyxa were developed. Overall, although our study shows that levan is not the only EPS produced by P. polymyxa, it represents a significant first step toward developing cost-effective 2,3-BD fermentation devoid of EPS-associated complications during downstream processing.


2021 ◽  
Vol 06 ◽  
Author(s):  
Ayekpam Chandralekha Devi ◽  
G. K. Hamsavi ◽  
Simran Sahota ◽  
Rochak Mittal ◽  
Hrishikesh A. Tavanandi ◽  
...  

Abstract: Algae (both micro and macro) have gained huge attention in the recent past for their high commercial value products. They are the source of various biomolecules of commercial applications ranging from nutraceuticals to fuels. Phycobiliproteins are one such high value low volume compounds which are mainly obtained from micro and macro algae. In order to tap the bioresource, a significant amount of work has been carried out for large scale production of algal biomass. However, work on downstream processing aspects of phycobiliproteins (PBPs) from algae is scarce, especially in case of macroalgae. There are several difficulties in cell wall disruption of both micro and macro algae because of their cell wall structure and compositions. At the same time, there are several challenges in the purification of phycobiliproteins. The current review article focuses on the recent developments in downstream processing of phycobiliproteins (mainly phycocyanins and phycoerythrins) from micro and macroalgae. The current status, the recent advancements and potential technologies (that are under development) are summarised in this review article besides providing future directions for the present research area.


2013 ◽  
Vol 2013 ◽  
pp. 1-12 ◽  
Author(s):  
Yujin Cao ◽  
Rubing Zhang ◽  
Chao Sun ◽  
Tao Cheng ◽  
Yuhua Liu ◽  
...  

Succinate is a valuable platform chemical for multiple applications. Confronted with the exhaustion of fossil energy resources, fermentative succinate production from renewable biomass to replace the traditional petrochemical process is receiving an increasing amount of attention. During the past few years, the succinate-producing process using microbial fermentation has been made commercially available by the joint efforts of researchers in different fields. In this review, recent attempts and experiences devoted to reduce the production cost of biobased succinate are summarized, including strain improvement, fermentation engineering, and downstream processing. The key limitations and challenges faced in current microbial production systems are also proposed.


2021 ◽  
Author(s):  
Benjamin Jester ◽  
Hui Zhao ◽  
Mesfin Gewe ◽  
Thomas Adame ◽  
Lisa Perruzza ◽  
...  

ABSTRACTArthrospira platensis (commonly known as spirulina) is a photosynthetic cyanobacterium1. It is a highly nutritious food that has been consumed for decades in the US, and even longer by indigenous cultures2. Its widespread use as a safe food source and proven scalability have driven frequent attempts to convert it into a biomanufacturing platform. But these were repeatedly frustrated by spirulina’s genetic intractability. We report here efficient and versatile genetic engineering methodology for spirulina that allows stable expression of bioactive protein therapeutics at high levels. We further describe large-scale, indoor cultivation and downstream processing methods appropriate for the manufacturing of biopharmaceuticals in spirulina. The potential of the platform is illustrated by pre-clinical development and human testing of an orally delivered antibody therapeutic against campylobacter, a major cause of infant mortality in the developing world and a growing antibiotic resistance threat3,4. This integrated development and manufacturing platform blends the safety of food-based biotechnology with the ease of genetic manipulation, rapid growth rates and high productivity characteristic of microbial platforms. These features combine for exceptionally low-cost production of biopharmaceuticals to address medical needs that are unfeasible with current biotechnology platforms.


Processes ◽  
2019 ◽  
Vol 7 (10) ◽  
pp. 667 ◽  
Author(s):  
Avraam Roussos ◽  
Nikiforos Misailidis ◽  
Alexandros Koulouris ◽  
Francesco Zimbardi ◽  
Demetri Petrides

Renewable liquid biofuels for transportation have recently attracted enormous global attention due to their potential to provide a sustainable alternative to fossil fuels. In recent years, the attention has shifted from first-generation bioethanol to the production of higher molecular weight alcohols, such as biobutanol, from cellulosic feedstocks. The economic feasibility of such processes depends on several parameters such as the cost of raw materials, the fermentation performance and the energy demand for the pretreatment of biomass and downstream processing. In this work, two conceptual process scenarios for isobutanol production, one with and one without integrated product removal from the fermentor by vacuum stripping, were developed and evaluated using SuperPro Designer®. In agreement with previous publications, it was concluded that the fermentation titer is a crucial parameter for the economic competitiveness of the process as it is closely related to the energy requirements for product purification. In the first scenario where the product titer was 22 g/L, the energy demand for downstream processing was 15.8 MJ/L isobutanol and the unit production cost of isobutanol was $2.24/L. The integrated product removal by vacuum stripping implemented in the second scenario was assumed to improve the isobutanol titer to 50 g/L. In this case, the energy demand for the product removal (electricity) and downstream processing were 1.8 MJ/L isobutanol and 10 MJ/L isobutanol, respectively, and the unit production cost was reduced to $1.42/L. The uncertainty associated with the choice of modeling and economic parameters was investigated by Monte Carlo simulation sensitivity analysis.


2020 ◽  
Vol 17 ◽  
pp. 717-730 ◽  
Author(s):  
Anniina J. Valkama ◽  
Igor Oruetxebarria ◽  
Eevi M. Lipponen ◽  
Hanna M. Leinonen ◽  
Piia Käyhty ◽  
...  

2020 ◽  
Vol 117 (5) ◽  
pp. 1348-1356 ◽  
Author(s):  
Ryosuke Mitsui ◽  
Riru Nishikawa ◽  
Ryosuke Yamada ◽  
Takuya Matsumoto ◽  
Hiroyasu Ogino

2012 ◽  
Vol 66 (2) ◽  
pp. 201-206
Author(s):  
Aleksandra Dimitrijevic ◽  
Dusan Velickovic ◽  
Ratko Jankov ◽  
Nenad Milosavic

Yeast Candida antarctica produces two lipase forms, which are widely used as catalysts in variety of organic reactions, many of which are applied on a large scale. In this work, production of two forms of lipase from C. antarctica DSM 70725 (CAL A and CAL B) was monitored during seven days of cultivation in the optimal medium using different electrophoretic and zymographic techniques. According to electrophoresis after silver staining, C. antarctica lipase A (molecular mass 45 kDa) was produced starting from the second day of cultivation. C. antarctica lipase B (CAL B) was also produced starting from the second day, but protein was present in the fermentation broth predominantly as dimer (molecular weight 66 kDa), while presence of monomeric form of CAL B (molecular weight of 33 kDa) was observed starting from the fourth day of cultivation. Both types of zymograms (based on hydrolysis and synthesis reactions) were used for detection of lipase activity in the fermentation broth. C. antarctica lipase A showed activity only in hydrolytic zymogram, when ?-naphtyl butyrate was used as substrate. In the same zymogram, with ?-naphtyl acetate as substrate no CAL A activity was detected. Similarly, CAL A showed no activity in synthesis based zymograms towards oleic acid and octanol as substrates, indicating that CAL A is not active towards very short or long-chain substrates. As opposite of CAL A, both monomeric and dimeric form of CAL B were detected in the all zymograms, suggesting that CAL B is active towards wide range of substrates, regardless to the chain length. Thus, zymogram based on hydrolysis of ?-naphtyl butyrate represents a simple method for monitoring the production of two forms of lipase from C. antarctica, that greatly differ in their characteristics.


2013 ◽  
Vol 644 ◽  
pp. 284-287
Author(s):  
Peng Fei Zhou ◽  
Zhi Ping Guo ◽  
Li Li Bai ◽  
Jin Zhong Yang ◽  
Yu Gang Meng ◽  
...  

The new plate heat exchanger with modular design is easy to realize the large-scale. It also has the performance advantage of low pressure drop and anticorrosion. The oil refining, chemical industry, steel and iron, metallurgy, electric power industries will be the future main application of it. But the designed engine for product is too big, the production cost is high, the production time is long, and it does not suit for processing experiment. Based on the above product structure and similarity theory, the paper designs another small type of reflux plate heat exchanger and the corresponding bench for testing.


Sign in / Sign up

Export Citation Format

Share Document